Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 63,100
+1,200 (1.94%)
At close: Feb 9, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 903.74 billion as of February 9, 2026.
Market Cap
903.74B
Enterprise Value
430.09B
Revenue
283.31B
Ranking
n/a
PE Ratio
9.66
Stock Price
63,100.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 903.74B, a decrease of -49.22%. That is a compound annual growth rate of -85.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 903.74B | -10.16% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mezzion Pharma | 4.22T |
| HK inno.N | 1.50T |
| G2GBIO | 1.31T |
| ImmuneOncia Therapeutics | 719.40B |
| Samyang Biopharm | 696.00B |
| HEM Pharma | 633.63B |
| CellBion | 324.00B |
| DAE HWA Pharmaceutical | 264.85B |